BrSHP2

General Information


DRACP ID  DRACP05932

Peptide Name   BrSHP2

Sequence  XRRKAFⓍHWYⓍG

Sequence Length  12

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Cancer targeted peptides Stapled Peptides Induce apoptosis Tubulin Inhibitors



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
MCF-7 Invasive breast carcinoma of no special type Carcinoma IC50=33.79 ± 2.34 μM MTT assay 24 h 1

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Tubulin

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Cyclic (Stapled)

Disulfide/Other Bond  Stapled: Ⓧ(7) and Ⓧ (11) are cross-linked by hydrocarbon stapling

N-terminal Modification  FITC, 5(6)-carboxy fluorescence

C-terminal Modification  Free

Other Modification  Ⓧ=(S)-2-(4-pentenyl) Ala; X=Phe-Br (para-Halo phenylalanine)

Chiral  L



Physicochemical Information


Formula  C58H75N19O8

Absent amino acids  CDEILMNPQSTV

Common amino acids  R

Mass  147273

Pl  11.53

Basic residues  4

Acidic residues  0

Hydrophobic residues  3

Net charge  4

Boman Index  -3213

Hydrophobicity  -117.5

Aliphatic Index  8.33

Half Life 
  /

Extinction Coefficient cystines  6990

Absorbance 280nm  635.45

Polar residues  2

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 36240440

Title  Evolution of Potential Antimitotic Stapled Peptides from Multiple Helical Peptide Stretches of the Tubulin Heterodimer Interface: Helix-Mimicking Stapled Peptide Tubulin Inhibitors

Doi 0.1021/acs.jmedchem.2c01116

Year  2022

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.